Sat, January 3, 2026

US and UK agree zero tariffs deal on pharmaceuticals

Marcus Ellington

By MARCUS ELLINGTON

US and UK agree zero tariffs deal on pharmaceuticals

A new deal between the US and the UK lets drugs from the UK get to the US without having to pay taxes.The deal makes sure that one of the most important parts of the UK economy can keep going without any more problems.This is good for the healthcare systems and supply chains in both countries.

People in charge from both sides have praised the deal, saying it will help the two countries work together better and keep the economy stable.

The fact that there would be no tariffs on goods coming from either country shows how strong their business ties are, especially when it comes to high-tech medical equipment.A lot of drugs come from the UK to other places. Keeping tariffs at zero should help protect jobs, new ideas, and investments.

The deal makes sure that the US can keep getting good drugs and medical technology from British companies.

A boost for drug companies and their employees

Business experts say that making tariffs less confusing helps supply chains run more smoothly, especially for products that are very important to global health.When trade terms stay the same, drug companies can plan their long-term research, production, and distribution without worrying that prices will suddenly go up.

After problems that have happened around the world in the past few years, the deal is also part of other efforts to make the medical supply chain stronger.


Marcus Ellington

Marcus Ellington

ABOUT AUTHOR

Marcus Ellington is a business journalist in the U.K. who writes about market trends, economic policy, and company strategy.Marcus has a background in finance and has been writing about how the country's economy is changing for years.He gives his work a clear, data-driven point of view.People in the U.K. know him for making boring financial news into interesting, easy-to-read stories.



Leave a Reply